Expanded OpenFDA Interface Aims To Improve Device Analysis, App Development In The US
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration says a new interface will let the medical device industry, researchers and other stakeholders better analyze device datasets available through Open.FDA.gov to determine their effectiveness and identify potential safety signals1.